AI in Clinical Trials Market to Reach USD 7.32 Bil...
Category : Clinical Trial Update 28 September 2026Market Expected to Grow at 15.5% CAGR From 2026 to 2034 The global AI in Clinical Trials Market i...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Kodiak Sciences to Report Phase 3 DAYBREAK Results...
Category : Clinical Trial Update 28 September 2026Topline Results Will Evaluate Treatments for Wet Age-Related Macular Degeneration Kodiak Sciences...
Gossamer Bio submits NDA to US FDA for seralutinib...
Category : Clinical Trial Update 26 September 2026Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commer...
Newron Provides Update on Phase 3 ENIGMA-TRS 2 Stu...
Category : Clinical Trial Update 26 September 2026Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical co...
Amgen’s Dazodalibep Meets Phase 3 OASIZ 301 Goal i...
Category : Clinical Trial Update 24 September 2026Phase 3 Study Shows Improvement in Systemic Disease Activity Amgen has reported positive topline...
Latest Newsletter Post
-
Kodiak Sciences to Report Phase 3 D..
28 September 2026
-
AI in Clinical Trials Market to Rea..
28 September 2026
-
Newron Provides Update on Phase 3 E..
26 September 2026
-
Gossamer Bio submits NDA to US FDA..
26 September 2026
-
Roche’s Sefaxersen Meets Phase III..
24 September 2026
